Cargando…
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression
Mutations in genes encoding SWI/SNF chromatin remodeling complexes are found in approximately 20% of all human cancers, with ARID1A being the most frequently mutated subunit. Here, we show that disruption of ARID1A homologs in a zebrafish model accelerates the onset and increases the penetrance of M...
Autores principales: | Shi, Hui, Tao, Ting, Abraham, Brian J., Durbin, Adam D., Zimmerman, Mark W., Kadoch, Cigall, Look, A. Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439613/ https://www.ncbi.nlm.nih.gov/pubmed/32832616 http://dx.doi.org/10.1126/sciadv.aaz3440 |
Ejemplares similares
-
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma
por: Zimmerman, Mark W., et al.
Publicado: (2021) -
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state
por: Weichert-Leahey, Nina, et al.
Publicado: (2023) -
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
por: Wang, Lu, et al.
Publicado: (2019) -
MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
por: De Wyn, Jolien, et al.
Publicado: (2021) -
Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights
por: Shendy, Noha A.M., et al.
Publicado: (2022)